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Abstract
Purpose. This study investigates the virulence and antimicrobial resistance in association with common clonal complexes
(CCs) of enteroaggregative Escherichia coli (EAEC) isolated from Bangladesh. The aim was to determine whether specific CCs
were more likely to be associated with putative virulence genes and/or antimicrobial resistance.
Methodology. The presence of 15 virulence genes (by PCR) and susceptibility to 18 antibiotics were determined for 151 EAEC
isolated from cases and controls during an intestinal infectious disease study carried out between 2007–2011 in the rural
setting of Mirzapur, Bangladesh (Kotloff KL, Blackwelder WC, Nasrin D, Nataro JP, Farag TH et al. Clin Infect Dis 2012;55:
S232–S245). These data were then analysed in the context of previously determined serotypes and clonal complexes defined
by multi-locus sequence typing.
Results. Overall there was no association between the presence of virulence or antimicrobial resistance genes in isolates of
EAEC from cases versus controls. However, when stratified by clonal complex (CC) one CC associated with cases harboured
more virulence factors (CC40) and one CC harboured more resistance genes (CC38) than the average. There was no direct
link between the virulence gene content and antibiotic resistance. Strains within a single CC had variable virulence and
resistance gene content indicating independent and multiple gene acquisitions over time.
Conclusion. In Bangladesh, there are multiple clonal complexes of EAEC harbouring a variety of virulence and resistance
genes. The emergence of two of the most successful clones appeared to be linked to either increased virulence (CC40) or
antimicrobial resistance (CC38), but increased resistance and virulence were not found in the same clonal complexes.
INTRODUCTION
Enteroaggregative Escherichia coli (EAEC) have been linked
to acute and persistent diarrhoea among children and adults
in developing countries [1–6] where malnutrition contrib-
utes to increasing the severity of symptoms and infection
can impair growth and development [7].
Strains of EAEC make a significant contribution to the bur-
den of gastrointestinal disease in Bangladesh either as an
important independent causal agent [8] or in combination
with other pathogens [1, 9, 10]. In many countries, bacterial
gastroenteritis is managed without recourse to antibiotics
but in severe cases, high-risk patients and chronic persistent
infections, specific therapy is warranted [11]. In Bangladesh,
symptoms of EAEC infection are often severe or persistent
and so antibiotic treatment is frequently recommended.
With the exception of one report highlighting an extended
spectrum beta-lactamase (ESBL)-producing strain of EAEC
from a recurrent urinary tract infection [12], there is very
little information published on resistance to antibiotics of
EAEC in Bangladesh, or indeed globally.
The causal link of EAEC in relation to disease in the human
population is not absolute [13]. Multiple studies have dem-
onstrated the heterogeneity of EAEC with respect to both
plasmid and chromosomal gene content [14, 15] and the
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association of single virulence factors with disease is con-
founded by the variation in genetic background of this
group [15]. An alternative approach is to define sub-groups
of EAEC, which are known to be present in multiple line-
ages of the E. coli population. Indeed multi-locus sequence
typing (MLST) has been used to define sub-groups of EAEC
associated, more or less, with disease [16], but few studies
have analysed MLST sub-groups for virulence gene content.
There are a number of EAEC putative virulence factors, the
majority of which are plasmid (pAA) borne [14, 17, 18].
The principal diagnostic target is aggR, which regulates the
transcription of other EAEC plasmid- and chromosomally-
encoded genes during the control of aggregative adherence
[19, 20]. There are currently five known multiple aggrega-
tive adherence fimbriae (AAF) subunits associated with
aggR positive EAEC: AAF/1, AAF/2, AAF/3, AAF/4 [21]
and AAF/5 [22] encoded by the genes aggA, aafA, aag3a,
aag4A and aaf5A respectively. Other plasmid-encoded
EAEC genes include the anti-aggregative transporter (aat)
responsible for transporting a protein called dispersin across
the membrane [23], the dispersin protein encoded by aap
[18], the enteroaggregative heat stable toxin 1 (EAST-1)
encoded by astA [24] and the plasmid-encoded heat-liable
cytotoxin encoded by pet [25]. Chromosomally encoded vir-
ulence factors include: the type VI secretion system on the
aggR-activated island, aaiC [26]; the mucinase protein
involved in colonisation encoded by pic [27]; the shigella
enterotoxin 1 (ShET1) toxin, encoded by set1A and set1B
[28]; the iron-repressible high-molecular-weight protein 2
encoded by irp2 [29] and the locus controlling intestinal
epithelial adherence and toxigenic invasion tia [30].
There are genetically related, clonal complexes (CCs) of EAEC
with a defined ability to cause disease [15, 16]. In the Chatt-
away et al. [16] study, Bangladesh EAEC isolates were found
in several of the EAEC complexes with the majority of strains
falling into CC38, CC295, CC31 CC10 and CC40 but assess-
ment of EAEC virulence genes or antibiotic resistance of these
key complexes was not undertaken. Understanding patho-
genic and resistant CCs of EAEC in Bangladesh can (1) help
clinical management of these infections to prevent malnutri-
tion and mortality and (2) have a baseline of data to assess
that will enable further studies to assess the global impact of
any major CCs. Here we report the virulence factors and anti-
microbial resistance (AMR) profiles associated with these
complexes. This is the first study analysing in detail EAEC iso-
lates from the rural setting of Mirzapur, Bangladesh [31]. The
aim of this study is to to seek an association between AMR,
ability to cause disease and genetic background of EAEC
strains from Bangladesh.
METHODS
Bacterial strains and serotyping
One hundred and fifty-seven isolates of EAEC originally
isolated between 2007–2011 from the rural setting of
Mirzapur, Bangladesh using presence of the aat or aaiC
gene by PCR as part of a case control study [32] were
included in this study. Cases were defined as having acute
onset of diarrhoea (3 abnormally loose stools in the previ-
ous 24 h) within 7 days of study enrolment. A control was
defined as having no diarrhoea in the previous 7 days
enrolled within the same community within 14 days of pre-
sentation of the index case [31].
The set comprised of 96 cases and 61 controls. Serotyping of
the somatic and flagella antigens [33] was carried out on the
heat stable lipopolysaccharide (LPS) (somatic or O) antigens
and the flagellar (H) antigens. Strains that failed to produce
LPS and could not be typed were termed ‘rough’ and those
that did not react with any sera in the serotyping scheme
were termed ‘O unidentifiable’ or ‘H unidentifiable’.
Multi-locus sequencing typing and genotyping
Extracted DNA was available for 151/157 EAEC Bangladesh
isolate strains from a previous study which had previously
defined their multi-locus sequence types [16]. The DNA
from 151 EAEC isolates was screened by PCR for the plas-
mid encoded virulence genes: aat, aap, astA, aggR, affA,
aafA, agg3A, agg4A, aaf5A and pet and chromosomal
encoded genes: pic, Set1A, aaiC and irp2 (Table S1, available
in the online Supplementary Material). The primers and
probes for aaf5A were designed as part of this study
FIM5_F 5¢-GACTGGATTCTTCAGCTTAAATTAAG-3¢,
FIM_R 5¢-TTCATTTGATGCTGGATTGA-3¢, FIM5_P
‘GAGCCCGAGCCTGTACATAGATTTGT’. Products were
amplified using the 7500 Fast Real-Time PCR System
(Applied Biosystems) with amplification conditions: 95

C
for 5min followed by 95

C for 30 s, then 60

C for 30 s and
72

C for 10 s. Controls used were as follows: O42 (aafA,
aat, aggR, pic, astA, set1A, aaiC, irp2, aap, pet), E099518
(aag3A), 8089 (agg4A), 601010 (tia), 900063 (aagA), 3036
(aaf5A). The total number of positive virulence genes was
counted in each strain to give a virulence score.
Phylotyping (A, B1, B2, and D) was determined by PCR
[34] for the sequence type (ST) complexes that contained 5
isolates or more.
A previous study [16] described an association of EAEC
CCs with disease. Therefore, the ten main EAEC CCs in
Bangladesh (CC10, 155, 165, 168, 295, 31, 38, 394, 40
and 720) were analysed for an association with virulence
and resistance. Data were analysed in Stata version 13.1
(StataCorp, College Station, Texas). T-tests were used to
compare means of continuous variables and the Chi-square
test for categorical variables, such as associations between
specific genes and the proportion of cases. Differences in
virulence score according to complex were examined via
multivariable linear regression.
Antimicrobial resistance typing
The antimicrobial drug susceptibilities of all 157 EAEC iso-
lates were determined using the agar incorporation break-
point method described in the British Society for
Antimicrobial Chemotherapy guidelines [35, 36]. The con-
centrations of the antibiotics used for testing were: colistin
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(2mg l 1), gentamicin (2mg l 1), amikacin (8mg l 1), strep-
tomycin (8 and 16mg l 1), tobramycin (2mg l 1), ertape-
nem (0.064 and 0.5mg l 1), cefoxitin (8mg l 1), ceftazidime
(0.5, 1 and 2mg l 1), cefotaxime (0.25, 0.5 and 1mg l 1), cef-
tiofur (1mg l 1), cefpirome (1mg l 1), chloramphenicol (8
and 16mg l 1), trimethoprim (2mg l 1), nalidixic acid
(16mg l 1), ciprofloxacin (0.064 and 0.5mg l 1), sulfameth-
oxazole (256mg l 1) and tetracycline (8mg l 1).
Isolates were screened by multiplex PCR for the presence of
CTX-M, AmpC, TEM, SHV, VEB, PER and GES beta-lacta-
mase genes and ESBL production was confirmed by double-
disc synergy test. Group 9 CTX-M genes were identified to
allele level by sequencing where possible [37]. Group 1
CTX-M alleles and their upstream genetic environments
were investigated by PCR and sequencing using primers
specific for ISEcp1-like and IS26-like elements [37].
RESULTS
Virulence of EAEC cases and controls versus clonal
complexes
Virulence gene content between cases and controls was het-
erogeneous (Tables S2 and S3) and none of the individual
genes were significantly associated with either cases
or controls. However, the average virulence score (total
number of virulence genes present) was higher in cases (7.3)
than controls (6.2) (Table 1) (P-value=0.027). The chromo-
somal gene irp2 was higher in cases (70%) than controls
(58%) but did not reach significance (P=0.107). There was
relatively low power to detect differences in individual genes
with the sample size collected in this study as only differen-
ces of 20% or more between cases and controls would
approach 80% power. Therefore modest differences could
not be ruled out (10–20%) in the proportion of genes
between cases and controls.
The virulence genes aggR, aat, aap, AAF1-4, astA, pet, pic,
setA, ipr2 and tia were significantly associated with the
common EAEC CCs [16]. There was no
statistical significant association with the common EAEC
CCs for aaf5A and aaiC (Table S4). Comparison of viru-
lence scores between EAEC CCs revealed that isolates from
CC40 and CC295 harboured more virulence factors than
other CCs (Table 2). Within CCs, there was no significant
association between fimbrial type and whether the strain
was from a case or control. ST165 strains (cases only) were
positive for agg3A and all ST40 strains (both cases and con-
trols) were positive for aafA.
Phylogrouping showed that CCs were evenly distributed
among three groups (A, B1, D) although no CC was associ-
ated with group B2. Isolates from group B1 had a higher
average virulence score (8.7) than isolates from group A
(6.1) and D (6.5) (Table 2) but there was no obvious associ-
ation with disease from the case control data. However, ana-
lysing the groups by sequence type revealed that B1 could
be further divided into three groups: CC155, 295 and 40
(Table 2). Comparison with the case control data showedTa
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that CC40 was also associated with disease (case control
study P=0.03 [16]) and was the sequence type that har-
boured the most virulence factors (10.4, Table 2). Thus
CC40 has been shown by two independent methods to be a
virulent subtype of EAEC.
Resistance of EAEC clonal complexes
The phenotypic antimicrobial typing results showed a high
incidence of multidrug resistance (MDR) in this dataset
(defined as resistant to three or more antibiotic classes).
MDR was identified in 119 (75.8%) of 157 isolates. Thirty-
two (20.4 %) of isolates were resistant to the third-genera-
tion cephalosporins (ceftazidime 0.25mg l 1 and cefotaxime
1mg l 1) and 120 (75.9%) were resistant to ampicillin (8mg
l 1). One hundred and ten (70.2 %) exhibited reduced sus-
ceptbility (0.064mg l 1 ciprofloxacin) and 21 were resistant
(0.5mg l 1 ciprofloxacin) to the quinolones. The isolates
were also resistant to streptomycin 16mg l 1 (n=49; 31%),
trimethoprim 2mg l 1 (n=88; 56%) and tetracycline 8mg
l 1 (n=70; 44%) (Table S5). Analysis of resistance gene con-
tent by CC indicated multiple drug resistance of strains
within these complexes (Table 3). Of the 32 presumptive
ESBL isolates, 28 had double-disk (DD) synergy and resis-
tance was encoded by blaCTX-M (blaCTX-M-9, n=17; blaCTX-
M-15, n=11) which were identified as the sole mechanism
explaining third-generation cephalosporin resistance.
DISCUSSION
This study showed that isolates of EAEC belonging to
CC295 and 40 were associated with the highest virulence
factor score, whereas ST165 and CC394 had the lowest viru-
lence factor scores. This supports previous evidence from
case control studies that highlighted CC40 as a potentially
virulent group of EAEC [16, 38]. In previous studies, it was
not always possible to correlate the presence of individual
EAEC virulence factors with disease [39, 40] but this study
showed an association between the presence of combined
EAEC virulence factors with disease (P=0.027; virulence
score in case versus control). While the individual virulence
genes were not independently associated with the ability to
cause disease (hence the non-significance association of
individual gene with cases), the number of virulence genes
present may increase the pathogenic potential of the strain.
The heterogeneity of virulence profiles (Tables 1 and 2) sug-
gests multiple acquisition events of different virulence
genes. Evolutionary analysis of the different EAEC com-
plexes have indicated that some clonal complexes have
evolved predominantly by recombination (such as CC38)
rather than mutation (such as CC10) [41]. Clonal com-
plexes that can successfully encounter multiple recombina-
tion events can easily acquire mobile genetic elements
without impact to survival of the organism. Although the
functions of many of the genes described here have been
published, a comprehensive understanding of all the gene
functions and how they interact with other genes has yet to
be fully elucidated.
We also considered the possibility that the presence of mul-
tiple virulence factors may be associated with a specific
genetic background (as defined by EAEC CC). ST40 has
been previously linked to a household outbreak of EAEC
O111:H21 encoding the stx2 gene in Northern Ireland pro-
viding further evidence that CC40 has the capacity to
acquire and maintain a repertoire of virulence genes [38].
The chromosomal marker aaiC is located on the AAI path-
ogenicity island that encodes a type VI secretion system reg-
ulated by the aggR activator [42]. The gene aaiC is an
important diagnostic marker for EAEC and is now used
alongside aat or aggR to detect EAEC. It has been postulated
that the presence of the AAI operon may be associated with
increased pathogenicity irrespective of other virulence fac-
tors [26]. However, as with previous studies [3, 14, 15, 43],
this study showed no statistical association with the pres-
ence of aaiC in cases versus controls [3, 10, 14, 15, 43, 44].
Previous studies have highlighted other main EAEC com-
plexes to be pathogenic including the EAEC CC38 associ-
ated with extra-intestinal infection, which had been
previously shown to have an average virulence score of 9
(including extra-intestinal virulence markers) [41] as did
CC10, also statistically shown to be associated with disease
in adults [16] and in children [15]. Since data from this
study has shown that virulence content is not directly pro-
portional to association with disease, it is suggested that the
content of known virulence genes for EAEC plays a role in
the ability to cause disease but also in biological success and
therefore advantageous to retain these genes as CC evolve.
This may explain why the virulence scores of strains within
the same complexes vary (Table 2).
CC38 (phylogroup D) is the most resistant of all of the CC
in this study (Table 3). CC38 has adapted to both gastroin-
testinal and extra-intestinal environments [15, 16, 41]. The
Table 2. Mean virulence score (and association with disease) of EAEC
complexes
Clonal
complex
Phylogroup Sample
size
Mean of
virulence
score
Association of
EAEC CC with
disease*
10 A 18 6.8 0.01
155 B1 8 6.6 0.2
165 A 5 4.6 0.3
168 A 5 6.8 0.2
295 B1 20 9.2 0.2
31 D 11 7.7 Associated with
controls=P0.005
38 D 21 6.3 0.3
394 D 7 5.6 0.56
40 B1 10 10.4 0.03
*Taken from Chattaway et al. study [16].
Mean of virulence scores per EAEC Clonal complex (CC) from Bangla-
desh with 5 or more samples. CC40 and 295 are the most virulent in
terms of average virulent gene content.
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ability to colonise multiple niches may provide an increased
opportunity to acquire resistance genes from a wide variety
of bacterial species. Recombination events are a major con-
tributory factor in the evolutionary history of CC38 [16]
and may facilitate its ability to adapt to retaining multiple
resistance mechanisms. CC10 is one of the largest CC in
this study and an ancestral group of multiple pathotypes of
E. coli. In CC10, mutation rather than recombination has
had a higher impact on the evolution of this group [15, 41]
and although the ability of CC10 to naturally evolve over
time has enabled this group to evolve into multiple patho-
types of E. coli, this study showed that CC10 was less resis-
tant than CC38 (Table 3). The results of this study showed
that some CC are more resistant than others and that strains
within a complex are not consistently resistant against the
same panel of antimicrobials indicating independent acqui-
sition of resistance mechanisms within a CC. As with the
heterogeneous virulence score and there was no direct link
between resistance with virulence in any of the CC.
Multidrug resistance was identified in over 75% of the iso-
lates including all of the main EAEC CCs (Tables 3 and S5).
There is little Bangladesh EAEC resistance data available for
comparison but the Talukdar et al. study screening E. coli
resistance from household water supply showed 36% of
MDR of the E. coli strains [45]. Although the MDR EAEC
strains from this study are relatively high, only ETEC and
EPEC pathotypes were detected in this study, and additional
studies in Bangladesh of EAEC resistance would be required
for a fairer comparison. The widespread use of antibiotics
has been linked with the selection of resistance mechanisms
in pathogenic and non-pathogenic isolates of E. coli [46].
Southeast Asia has been identified as a hotspot for the emer-
gence of MDR in both extra-intestinal bacteria and gastro-
intestinal pathogens [47]. Despite this fact, the level of
MDR detected in the set of EAEC from Bangladesh is high,
and includes a high percentage of low level quinolone resis-
tance and ESBL-producing strains. Ciprofloxacin is often
used to treat gastrointestinal infections so increasing resis-
tance in these isolates is of concern [48]. Furthermore, it is
generally accepted that gut pathogens and gut commensals
act as a reservoir of resistance genes that may be acquired
by extra-intestinal pathogens associated with life-threaten-
ing conditions, such as septicaemia and pneumonia [49].
In conclusion we believe that the definition of the EAEC
group of bacteria includes a mixture of commensal bacteria,
opportunistic pathogens and primary pathogens. Only by
defining the genetic basis of virulence and biological success
in these three distinct groups of EAEC will we be able to
understand the association with gastrointestinal disease.
This study shows that it is possible to define pathogenic and
MDR CCs of EAEC and that EAEC CC40 is likely to repre-
sent a true pathogen.
Funding information
This study was supported by Gastrointestinal Bacteria Reference Unit,
Public Health England, International Centre for Diarrhoeal Disease
Research, Bangladesh, Society for Applied Microbiology (Supervisor
fund) and Society for General Microbiology (Presidents fund). The fun-
ders had no role in study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Acknowledgements
Acknowledgements to the scientists involved in the case control stud-
ies, diagnostic and reference laboratories. Thank you to Dawn Hedges
and Amy Gentle for Serotyping and Yoshini Taylor and Vivienne
DoNascimento for identification at the Gastrointestinal Bacteria Refer-
ence Unit (GBRU), PHE, and Benjamin Evens (UEA) for proof reading
the article. Thank you to Mark Achtman, University of Warwick, UK and
his group for development, management and access and to the public
database as well as the scientists who have submitted their data on
multiple studies.
Conflicts of interest
The authors declare that there are no conflicts of interest.
Ethical statement
All data was anonymized for the study and ethics approval was not
required.
References
1. Albert MJ, Faruque AS, Faruque SM, Sack RB, Mahalanabis D.
Case-control study of enteropathogens associated with childhood
diarrhea in Dhaka, Bangladesh. J Clin Microbiol 1999;37:3458–
3464.
2. Araujo JM, Tabarelli GF, Aranda KR, Fabbricotti SH, Fagundes-
Neto U et al. Typical enteroaggregative and atypical entero-
pathogenic types of Escherichia coli are the most prevalent
diarrhea-associated pathotypes among Brazilian children. J Clin
Microbiol 2007;45:3396–3399.
3. Boisen N, Scheutz F, Rasko DA, Redman JC, Persson S et al.
Genomic characterization of enteroaggregative Escherichia coli
from children in Mali. J Infect Dis 2012;205:431–444.
4. Cravioto A, Tello A, Navarro A, Ruiz J, Villafan H et al. Association
of Escherichia coli HEp-2 adherence patterns with type and dura-
tion of diarrhoea. Lancet 1991;337:262–264.
5. Okeke IN, Lamikanra A, Czeczulin J, Dubovsky F, Kaper JB et al.
Heterogeneous virulence of enteroaggregative Escherichia coli
strains isolated from children in Southwest Nigeria. J Infect Dis
2000;181:252–260.
6. Okeke IN, Nataro JP. Enteroaggregative Escherichia coli. Lancet
Infect Dis 2001;1:304–313.
7. Roche JK, Cabel A, Sevilleja J, Nataro J, Guerrant RL. Enteroag-
gregative Escherichia coli (EAEC) impairs growth while malnutri-
tion worsens EAEC infection: a novel murine model of the
infection malnutrition cycle. J Infect Dis 2010;202:506–514.
8. Liu J, Kabir F, Manneh J, Lertsethtakarn P, Begum S et al. Devel-
opment and assessment of molecular diagnostic tests for 15
enteropathogens causing childhood diarrhoea: a multicentre
study. Lancet Infect Dis 2014;14:716–724.
9. Haider K, Faruque SM, Shahid NS, Albert MJ, Nahar S et al.
Enteroaggregative Escherichia coli infections in Bangladeshi chil-
dren: clinical and microbiological features. J Diarrhoeal Dis Res
1991;9:318–322.
10. Taniuchi M, Sobuz SU, Begum S, Platts-Mills JA, Liu J et al. Etiol-
ogy of diarrhea in Bangladeshi infants in the first year of life ana-
lyzed using molecular methods. J Infect Dis 2013;208:1794–1802.
11. Li Z, Vaziri H. Treatment of chronic diarrhoea. Best Pract Res Clin
Gastroenterol 2012;26:677–687.
12. Ahmed D, Sultana N, Hossain A, Sadique T, Islam N et al. Recur-
rent urinary tract infection due to co-infection with extended spec-
trum b-lactamase-producer uropathogenic Escherichia coli and
enteroaggregative E. coli. JMM Case Rep 2014;1.
13. Chattaway MA, Harris R, Jenkins C, Tam C, Coia JE et al. Investi-
gating the link between the presence of enteroaggregative
Escherichia coli and infectious intestinal disease in the United
Kingdom, 1993 to 1996 and 2008 to 2009. Euro Surveill 2013;18:
20582.
Chattaway et al., Journal of Medical Microbiology 2017;66:1429–1435
14 4
Downloaded from www.microbiologyresearch.org by
IP:  192.38.90.17
On: Thu, 09 Nov 2017 12:05:27
14. Jenkins C, Chart H, Willshaw GA, Cheasty T, Smith HR. Genotyp-
ing of enteroaggregative Escherichia coli and identification of tar-
get genes for the detection of both typical and atypical strains.
Diagn Microbiol Infect Dis 2006;55:13–19.
15. Okeke IN, Wallace-Gadsden F, Simons HR, Matthews N, Labar AS
et al. Multi-locus sequence typing of enteroaggregative Escherichia
coli isolates from Nigerian children uncovers multiple lineages.
PLoS One 2010;5:e14093.
16. Chattaway MA, Jenkins C, Rajendram D, Cravioto A, Talukder KA
et al. Enteroaggregative Escherichia coli have evolved indepen-
dently as distinct complexes within the E. coli population with
varying ability to cause disease. PLoS One 2014;9:e112967.
17. Cerna JF, Nataro JP, Estrada-Garcia T. Multiplex PCR for detec-
tion of three plasmid-borne genes of enteroaggregative Escheric-
hia coli strains. J Clin Microbiol 2003;41:2138–2140.
18. Piva IC, Pereira AL, Ferraz LR, Silva RS, Vieira AC et al. Virulence
markers of enteroaggregative Escherichia coli isolated from chil-
dren and adults with diarrhea in Brasília, Brazil. J Clin Microbiol
2003;41:1827–1832.
19. Nataro JP, Yikang D, Yingkang D, Walker K. AggR, a transcrip-
tional activator of aggregative adherence fimbria I expression in
enteroaggregative Escherichia coli. J Bacteriol 1994;176:4691–
4699.
20. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol
Rev 1998;11:142–201.
21. Boisen N, Ruiz-Perez F, Scheutz F, Krogfelt KA, Nataro JP. Short
report: high prevalence of serine protease autotransporter cyto-
toxins among strains of enteroaggregative Escherichia coli. Am J
Trop Med Hyg 2009;80:294–301.
22. Prager R, Lang C, Aurass P, Fruth A, Tietze E et al. Two novel
EHEC/EAEC hybrid strains isolated from human infections. PLoS
One 2014;9:e95379.
23. Nishi J, Sheikh J, Mizuguchi K, Luisi B, Burland V et al. The export
of coat protein from enteroaggregative Escherichia coli by a spe-
cific ATP-binding cassette transporter system. J Biol Chem 2003;
278:45680–45689.
24. Savarino SJ, Fasano A, Robertson DC, Levine MM. Enteroaggre-
gative Escherichia coli elaborate a heat-stable enterotoxin demon-
strable in an in vitro rabbit intestinal model. J Clin Invest 1991;87:
1450–1455.
25. Sheikh J, Czeczulin JR, Harrington S, Hicks S, Henderson IR et al.
A novel dispersin protein in enteroaggregative Escherichia coli.
J Clin Invest 2002;110:1329–1337.
26. Dallman TJ, Chattaway MA, Cowley LA, Doumith M, Tewolde R
et al. An investigation of the diversity of strains of enteroaggrega-
tive Escherichia coli isolated from cases associated with a large
multi-pathogen foodborne outbreak in the UK. PLoS One 2014;9:
e98103.
27. Henderson IR, Czeczulin J, Eslava C, Noriega F, Nataro JP. Char-
acterization of pic, a secreted protease of Shigella flexneri and
enteroaggregative Escherichia coli. Infect Immun 1999;67:5587–
5596.
28. Fasano A, Noriega FR, Maneval DR, Chanasongcram S, Russell R
et al. Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a
active in rabbit small intestine in vivo and in vitro. J Clin Invest
1995;95:2853–2861.
29. Schubert S, Rakin A, Karch H, Carniel E, Heesemann J. Preva-
lence of the "high-pathogenicity island" of Yersinia species among
Escherichia coli strains that are pathogenic to humans. Infect
Immun 1998;66:480–485.
30. Fleckenstein JM, Kopecko DJ, Warren RL, Elsinghorst EA. Molec-
ular characterization of the tia invasion locus from enterotoxigenic
Escherichia coli. Infect Immun 1996;64:2256–2265.
31. Kotloff KL, Blackwelder WC, Nasrin D, Nataro JP, Farag TH et al.
The Global Enteric Multicenter Study (GEMS) of diarrheal disease
in infants and young children in developing countries:
epidemiologic and clinical methods of the case/control study. Clin
Infect Dis 2012;55:S232–S245.
32. Kotloff KL, Nataro JP, Blackwelder WC, Nasrin D, Farag TH et al.
Burden and aetiology of diarrhoeal disease in infants and young
children in developing countries (the Global Enteric Multicenter
Study, GEMS): a prospective, case-control study. Lancet 2013;382:
209–222.
33. Gross RJ, Rowe B. Serotyping of Escherichia coli. In: Sussman M
(editor). The Virulence of Escherichia coli. Cambridge: CambridgeU-
niversity Press; 1985. pp. 345–360.
34. Doumith M, Day MJ, Hope R, Wain J, Woodford N. Improved multi-
plex PCR strategy for rapid assignment of the four major
Escherichia coli phylogenetic groups. J Clin Microbiol 2012;50:
3108–3110.
35. Andrews JM, BSAC Working Party on Susceptibility Testing FT.
BSAC standardized disc susceptibility testing method.
J Antimicrob Chemother 2001;48:43–57.
36. Howe RA, Andrews JM, BSAC Working Party on Susceptibility
Testing. BSAC standardized disc susceptibility testing method
(version 11). J Antimicrob Chemother 2012;67:2783–2784.
37. Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid
detection of genes encoding CTX-M extended-spectrum b-lacta-
mases. J Antimicrob Chemother 2006;57:154–155.
38. Dallman T, Smith GP, O’Brien B, Chattaway MA, Finlay D et al.
Characterization of a verocytotoxin-producing enteroaggregative
Escherichia coli serogroup O111:H21 strain associated with a
household outbreak in Northern Ireland. J Clin Microbiol 2012;50:
4116–4119.
39. Bafandeh S, Haghi F, Zeighami H. Prevalence and virulence char-
acteristics of enteroaggregative Escherichia coli in a case-control
study among patients from Iran. J Med Microbiol 2015;64:519–524.
40. Vila J, Vargas M, Henderson IR, Gascón J, Nataro JP. Enteroag-
gregative Escherichia coli virulence factors in traveler’s diarrhea
strains. J Infect Dis 2000;182:1780–1783.
41. Chattaway MA, Jenkins C, Ciesielczuk H, Day M, Donascimento V
et al. Evidence of evolving extraintestinal enteroaggregative
Escherichia coli ST38 clone. Emerg Infect Dis 2014;20:1935–1937.
42. Dudley EG, Thomson NR, Parkhill J, Morin NP, Nataro JP. Proteo-
mic and microarray characterization of the AggR regulon identi-
fies a pheU pathogenicity island in enteroaggregative Escherichia
coli. Mol Microbiol 2006;61:1267–1282.
43. Lima IF, Boisen N, Quetz JS, Havt A, de Carvalho EB et al.
Prevalence of enteroaggregative Escherichia coli and its virulence-
related genes in a case-control study among children from North-
Eastern Brazil. J Med Microbiol 2013;62:683–693.
44. Dutta S, Guin S, Ghosh S, Pazhani GP, Rajendran K et al. Trends
in the prevalence of diarrheagenic Escherichia coli among hospi-
talized diarrheal patients in Kolkata, India. PLoS One 2013;8:
e56068.
45. Talukdar PK, Rahman M, Rahman M, Nabi A, Islam Z et al. Antimi-
crobial resistance, virulence factors and genetic diversity of
Escherichia coli isolates from household water supply in Dhaka,
Bangladesh. PLoS One 2013;8:e61090.
46. Livermore DM, Winstanley TG, Shannon KP. Interpretative read-
ing: recognizing the unusual and inferring resistance mechanisms
from resistance phenotypes. J Antimicrob Chemother 2001;48:87–
102.
47. Molton JS, Tambyah PA, Ang BS, Ling ML, Fisher DA. The global
spread of healthcare-associated multidrug-resistant bacteria: a
perspective from Asia. Clin Infect Dis 2013;56:1310–1318.
48. Steffen R, Hill DR, Dupont HL. Traveler’s diarrhea: a clinical
review. JAMA 2015;313:71–80.
49. Sommer MOA, Dantas G, Church GM. Functional characterization
of the antibiotic resistance reservoir in the human microflora.
Science 2009;325:1128–1131.
Chattaway et al., Journal of Medical Microbiology 2017;66:1429–1435
14 5
